Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Recipient : LG Chem
Deal Size : Inapplicable
Deal Type : Inapplicable
LG Chem enters Chinese osteoarthritis treatment market
Details : Hyruan One (hyaluronic acid) is a small molecule, dihydrofolate reductase inhibitor, given intra-articularly. It is China’s first single-injection osteoarthritis treatment.
Product Name : Hyruan One
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 07, 2024
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Recipient : LG Chem
Deal Size : Inapplicable
Deal Type : Inapplicable